Difference between revisions of "Category:Graft versus host disease medications"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Warner-admin moved page Category:Graft versus host disease (GVHD) medications to Category:Graft versus host disease medications without leaving a redirect) |
Warner-admin (talk | contribs) m (Text replacement - "Category:Transplant medications" to "") |
||
| Line 1: | Line 1: | ||
Medications used to treat the symptoms of [[graft versus host disease (GVHD)]]. [[Ibrutinib (Imbruvica)]] is the only currently ''FDA-approved'' therapy for the treatment of chronic GVHD. | Medications used to treat the symptoms of [[graft versus host disease (GVHD)]]. [[Ibrutinib (Imbruvica)]] is the only currently ''FDA-approved'' therapy for the treatment of chronic GVHD. | ||
| − | |||
| − | |||
Revision as of 22:49, 30 May 2019
Medications used to treat the symptoms of graft versus host disease (GVHD). Ibrutinib (Imbruvica) is the only currently FDA-approved therapy for the treatment of chronic GVHD.
Pages in category "Graft versus host disease medications"
The following 9 pages are in this category, out of 9 total.